Background: Human rhinoviruses (HRV) cause a wide spectrum of disease, ranging from a mild influenza-like illness (ILI) to severe respiratory infection. Molecular epidemiological data are limited for HRV circulating in the Southern Hemisphere. Discordant branching was seen within HRV A group: two sequences clustering as A in the VP4/VP2 tree branched within the C/A subspecies in the 5′UTR tree, and one sequence showed identity to different HRV A strains in the two genes. The prevalence of HRV C and C/A species was greater in paediatric compared to adult patients (47.9% vs 25.5%, P = .032).
respiratory illness throughout the year, but peak incidence occurs in early autumn and spring in temperate climates. 6 Early molecular analyses of the HRV capsid protein coding regions clustered different serotypes into two distinct species, HRV A and HRV B.
8 In 2007, a new HRV genetic variant (subsequently designated HRV C) was identified in patients with severe pneumonia from the United
States of America (USA), Germany, Hong Kong, Australia and China.
9-13
Severe respiratory disease and asthma exacerbations in children were observed. 11,14 HRV C has been further divided into two subspecies, HRV Cc and HRV Ca. 15 HRV C strains are difficult to grow in cell lines known to support the growth of other rhinoviruses, 11 although two HRV C isolates have been propagated in nasal epithelial cell cultures. 16 There are limited molecular epidemiological data on HRV circulating in the Southern Hemisphere, including Australia. This study aimed to identify the species and genotypes of HRV from clinical samples collected in Sydney, Australia, over four consecutive years by analysing the nucleotide homology in the 5′UTR, VP4 and part of the VP2 capsid protein coding regions. 
| MATERIALS AND METHODS

| Clinical samples
| Primers and probes
Primers used to amplify all picornaviruses, 18 the HRV-specific probes 5′UTR and VP4-VP2 gene sequencing primers are listed in Table 1 .
The RT-PCR probe sequences were designed to include most HRV sequences available in GenBank ® in 2007, and sequences generated from the present study.
| RNA extraction
RNA was prepared directly from combined NTS or NPA using Roche High Pure RNA kits (Roche, Mannheim, Germany).
| Real-time reverse-transcriptase PCR (RT-PCR)
The cDNA was reverse-transcribed from 10 μL of specimen RNA using 100 units of SuperScript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA) and 4 μL used for real-time PCR as described previously. 19 Amplification was performed in glass capillaries on 
| Sequencing PCR
Human rhinoviruses RT-PCR-positive samples were then tested using UTR primers EV140 and EV170 to amplify a 395-bp product.
20
Where RNA was available, samples were amplified with primers RHI3A and EVP4R, generating a 638-bp fragment that included part of 5′UTR, all of VP4 and part of VP2 regions. 18, 21 
| RESULTS
| rt-pcr
| Sequencing PCR
One hundred and two samples had RNA available for sequencing; 94 samples were amplified using primers EV140 and EV170, 
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| Phylogenetic analysis
Using BLAST ® , nearly all the sequences showed >98% similarity to one or more HRV sequences with partial cds available in GenBank ® .
These were approximately 390-420 bp and did not cover the full sequence from 5′UTR to VP2 of our study samples, and were not included in the construction of the ML tree.
As the data size was large, it was not possible to include each one of the HRV prototype sequences in the tree construction. Figure 1 shows the ML tree for the 5′UTR for all 93 sequences, and Figs 2 and 3 show the ML trees, respectively, of VP4/VP2 and 5′UTR/VP4/VP2
regions of the 65 samples. Tables S4 and S5 , respectively (supplementary section). In comparing the phylogeny between VP4/VP2 and 5′UTR, 80% and 82% ID to C-DQ875932 strain and samples in that cluster and similar identity to A15 and its cluster in the UTR tree, but in the VP4/VP2 tree the two samples showed 61% identity to C-DQ875932 and lower to other C strains and 62% and 80% identity to A 15 and 1B, respectively.
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Maximum-likelihood tree of the 5′UTR/VP4/VP2 region, showing relationships of clinical strains, newly described strains and prototype strains of HRV (constructed as described for Fig. 1 ). Samples with asterisk (*) denote strains that grouped as C in the VP4/VP2 region, but grouped with HRV A species in 5′UTR analysis. Discordant branches in the VP4/VP2 and 5′UTR sequences are indicated by • Two samples MS07-18 (97% homology to A65-JF781504) and MS08-7 (closest homology to A71-JX025555) grouped in a major branch with known strains of HRV Ca subspecies (78%-83% identity to C-EF077280 and 74% to 1B). In VP4/VP2, the identity for MS07-18 was 67.2% to EF077280, but maintained around 75% to HRV A viruses like 1B, 55 and 33 reference strains. A VP4/VP2 sequence was not available for MS08-7.
Another sample (CS09-2) that was closest to A67 (not shown) in VP4/VP2 branched separately and clustered with A89 along with sample MS06-2. CS09-2 showed 77.7% relatedness to A89 in the VP4/VP2 region and greater than 95% in the UTR region.
Samples with sequences that clustered with more than 99% identity (six samples with C-EU840952, four samples with C-JQ994498, six samples with A-1B-D00239, four samples with A21-FJ445121; Fig. 2 ) were all collected from the same year.
In the two families with presumed household transmission of HRV, samples MS06-4 and MS06-6 collected from mother and child shared the same HRV A strain. Similarly, MS07-3, MS07-4 and MS07-5 collected from both parents and child shared the same HRV C strain.
| VP4/VP2 coding region
The 65 sample sequences segregated into three phylogenetically dis- 
| 5′UTR/VP4/VP2 region
The grouping of samples as C and CA in the 5′UTR/VP4/VP2 analysis was very similar to that seen in the 5′UTR analysis. The discordant branching pattern seen with samples MS06-3 and HRV A12
(EF173415), MS07-18 and MS08-7 and CS09-2 (indicated with •) in the 5′UTR ML tree was not seen; it was in agreement with that seen in the VP4/VP2 ML tree.
| Prevalence of HRV C according to age groups
In The distribution of the different HRV subtypes is shown in Table 3 .
Both HRV A and C or C/A variant were detected in higher numbers than HRV B. Human rhinoviruses C or C/A variant was detected more to which the clinical samples showed greatest homology. The few field isolates compared were closely identified with the reference types as minor variants.
In our study, the sequences grouped into three phylogenetically distinct species: A (52.6%), C/CA (37.6%) and B (9.6%). However, there was discordance between proposed phylogeny groups when sequences from the 5′UTR and VP4/VP2 coding regions were analysed. Sixteen of the 20 samples that clustered as HRV C in the VP4/ VP2 ML tree segregated as A in the 5′UTR analysis, as did some of the early, well-characterized HRV C strains from New York (EU840952 and DQ875932), 23, 26 San Francisco (EF077279 and EF077280),
25
Hong Kong Special Administrative Region (EF582387) 11 and China (GQ223227). 15 Twelve of 28 sequences with only UTR sequences also segregated along with the above-mentioned reference C strains, branching in two major subgroups within HRV A. These have been labelled in this study as C/A, clustering with C strains, but grouping as A in the 5′UTR region: these formed 30% of the clinical sequences. Huang et al. 15 reported similar clustering of field strains in their study and designated the above C strains (EU840952, DQ875932, EF077279, EF077280, GQ223227 and EF582387) as Ca, a subspecies of HRV C that clustered differently to HRV A, HRV B and HRV C in the UTR. They further showed that HRV Ca subspecies were formed from interspecies recombination in the 5′UTR region. Similar inconsistent clustering of field strains as compared to VP4/VP2 was also reported in the 3D polymerase-coding region as well as 5′UTR region. 30 Three discordant branching events were seen in our analyses. MS07-18
(identity to A65) in one branch and MS06-3 along with HRV A12 in another branch segregated as A in the VP4/VP2 analysis, but localized within the Ca subspecies in the 5′UTR analysis. 34 found that while branching orders of VP1, VP4/VP2 and 3D pol trees were identical, greater than 60% of C variants in their study showed recombination with A sequences in the 5′UTR. They were able to map two recombination hot spots in the 5′UTR region. The amplification of the VP1 coding region is rather difficult, requiring culture isolates and multiple sets of primers. 26, 34 The clustering of HRV C as C and C/A when 5′UTR region was included in the analysis (Figs 1 and 3 ) in our study may suggest that they are true C species that showed recombination with A in the 5′UTR.
In this study, the 5′UTR primers and the primers chosen to amplify the entire VP4 and partial VP2 region produced amplicons with overlapping sequences that resulted in an approximately 900-bp continuous sequence. We used a single set of primers for each of the two PCR assays but did not use cloning, which has been used in other studies. 24, 35 Most studies using the VP1 protein coding region for genetic analysis used multiple degenerate primer pairs on clinical samples or culture isolates to achieve the sequences of interest. Using only cell culture isolates rather than clinical samples to study the variation in phylogenetic relationship among field isolates may not be entirely accurate as cell lines generally favour the selection of certain virus strains, failing to detect other fastidious strains. Sequencing PCR products directly from clinical samples is reflective of a true representation, but the sensitivity of PCR primers varies.
Real-time diagnostic PCR primers target the 5′UTR, a region with high interstrain homology, because of the ease of using a single set of primers that detect the majority of HRV strains. However, HRV strains with low copy numbers may remain undetected. In this study, the sensitivity of the 5′UTR sequencing primers and the second set of primers for the amplification of the full length of the VP4 and part of VP2 in comparison with the real-time assay was 92.1% and 69.56%, respectively. 20 Unlike others investigators, we did not find co-infections by multiple HRV strains. 12, 36 Two incidences of household HRV transmission were suggested by the sequences of all samples in each household showing 99% homology.
It is unclear whether the severity of infections caused by HRV C species is greater compared to HRV A and HRV B. The mask study had 2.5 times more children than adults who were positive for HRV, but the study selected children with a febrile respiratory illness, with well adult contacts at baseline; children who had specimens collected all presented to a paediatric ED. The majority of these HRV sequences were either C or the C/A variant (16/27) In conclusion, the present study shows that sequencing of one region alone is insufficient for determining the lineage of the HRV variants. The presence of many diverse strains has become apparent, and it is likely that more will emerge.
Genotypic assignment and identification of HRV types will facilitate monitoring of emerging novel variants, and investigations into type-associated differences in disease epidemiology, transmission and outcomes.
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